A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia . The drug, tirzepatide, is sold under ...

USA: A recent narrative review has highlighted the effectiveness of GLP-1 receptor agonists (RAs) in treating type 2 diabetes and obesity. These medications, which stimulate the glucagon-like ...

A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia.Authors Paul Joyce ...

Support for people living with obesity is “insufficient”, experts have said after a new report revealed that some patients ...

And I think that’s very naive as well to think that that is the case.” Mounjaro, which is made by Lilly, is a glucagon-like ...

Some people who lose weight successfully might not feel entirely like themselves after the weight comes off. “Well, you do ...

Retired Oak Ridge, Tennessee, physician notes the downside of a class of drugs − GLP-1s − first approved for treating ...

For adolescents with obesity, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is associated with a reduc ...

SGLT-2 inhibitors were associated with the lowest risk for incidental dementia relative to DPP-4 inhibitors and GLP-1RAs in type 2 diabetes.

Obesity treatment should start at a young age, he said, because if you have overweight at ages 3-6 years, the likelihood of ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Semaglutide use was associated with a lower risk for opioid overdose than other antidiabetic medications in comorbid type 2 diabetes and OUD.